Physician
Bonner General Hospital INC.
Bonner General Hospital INC. was paid $1.57M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.
33Billing provider infoBONNER GENERAL HOSPITAL INC.
SANDPOINT, ID 83864
SANDPOINT, ID 83864
33aNPI1154563963assigned 03/26/2009
33bProvider typeEmergency Medicine Physician
28Total paid$1.57M
24GClaims84,042
24DCodes billed100
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Idaho
Rank by total paid#7 of 26
Median peer was paid$143K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,103 | $449K | |
| 2019 | 24,721 | $451K | |
| 2020 | 13,067 | $271K | |
| 2021 | 5,645 | $116K | |
| 2022 | 6,477 | $126K | |
| 2023 | 6,432 | $110K | |
| 2024incomplete | 2,597 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 4,798 | 3,963 | $219K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 3,802 | 2,758 | $217K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8.0% | 1,633 | 592 | $125K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7.3% | 1,987 | 597 | $114K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.5% | 3,673 | 1,147 | $101K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 6.1% | 2,576 | 863 | $96K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 626 | 403 | $74K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.7% | 2,537 | 2,061 | $58K |
| 80053 | Comprehensive metabolic panel | 2.5% | 6,552 | 5,328 | $39K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 1,915 | 1,310 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 8,649 | 6,831 | $36K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,044 | 899 | $35K |
88 more codes
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.4% | 945 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 919 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 516 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 356 | $20K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 1,169 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,357 | $18K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 348 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,004 | $15K |
| 99285 | Emergency room visit (most serious) | <1% | 223 | $13K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 311 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,150 | $12K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 298 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 309 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 309 | $11K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,251 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,323 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,323 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 238 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 176 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,289 | $8K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 170 | $8K |
| 76801 | <1% | 157 | $8K | |
| 86780 | <1% | 525 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 76 | $6K |
| 87653 | <1% | 161 | $6K | |
| 97161 | <1% | 108 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 80 | $5K |
| 84484 | <1% | 1,175 | $5K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 501 | $4K |
| 86850 | <1% | 623 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 693 | $4K |
| 86703 | <1% | 306 | $4K | |
| 87205 | <1% | 1,184 | $4K | |
| 83690 | <1% | 700 | $3K | |
| 80061 | Lipid panel | <1% | 403 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 144 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 116 | $3K |
| 87077 | <1% | 485 | $3K | |
| 81001 | <1% | 1,737 | $3K | |
| 87340 | <1% | 274 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 999 | $3K |
| 87186 | <1% | 428 | $3K | |
| 80305 | <1% | 282 | $3K | |
| 86900 | <1% | 628 | $2K | |
| 86901 | <1% | 627 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $2K |
| 86762 | <1% | 169 | $2K | |
| 81025 | <1% | 317 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 746 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 397 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $2K |
| 81003 | <1% | 793 | $2K | |
| 87081 | <1% | 263 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 41 | $2K |
| 85610 | <1% | 646 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 259 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 35 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 29 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 207 | $1K |
| 86140 | <1% | 285 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $1K |
| 83605 | <1% | 291 | $1K | |
| 85027 | <1% | 184 | $986.17 | |
| 82948 | <1% | 142 | $908.73 | |
| 84703 | <1% | 118 | $811.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 525 | $770.78 |
| 83735 | <1% | 146 | $744.24 | |
| 73630 | <1% | 72 | $735.77 | |
| 85007 | <1% | 177 | $507.13 | |
| 97010 | <1% | 1,017 | $401.72 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 102 | $374.49 |
| 82950 | <1% | 69 | $326.74 | |
| 83880 | <1% | 13 | $273.03 | |
| 84100 | <1% | 48 | $206.55 | |
| 82550 | <1% | 51 | $203.84 | |
| 84439 | <1% | 26 | $190.38 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 24 | $183.60 |
| 73610 | <1% | 19 | $177.14 | |
| 87040 | <1% | 36 | $174.64 | |
| 85379 | <1% | 27 | $146.46 | |
| 85651 | <1% | 51 | $142.30 | |
| 87070 | <1% | 14 | $122.82 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $113.58 |
| 82728 | <1% | 12 | $106.05 | |
| 85730 | <1% | 14 | $41.21 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 236 | $36.33 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $34.76 |
| A9270 | Non-covered item or service | 0% | 108 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENNESSY, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Bonner General Hospital INC | Sandpoint, ID | $518K |
| Bonner General Hospital, INC | Sandpoint, ID | $49K |
| Bonner General Hospital, INC | Sandpoint, ID | $7K |
| Bonner General Hospital, INC | Sandpoint, ID | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.